NovoCure Limited (NVCR) Gross margin 2017–2026
NovoCure Limited (NVCR) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.5%FY2026 · since FY2017: 44.2% → 74.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 74.5% | -2.8 pp |
| FY2025 | 77.3% | +2.5 pp |
| FY2024 | 74.8% | -3.8 pp |
| FY2023 | 78.6% | +0.1 pp |
| FY2022 | 78.5% | +0.1 pp |
| FY2021 | 78.5% | +3.7 pp |
| FY2020 | 74.8% | +7.0 pp |
| FY2019 | 67.7% | -0.9 pp |
| FY2018 | 68.6% | +24.4 pp |
| FY2017 | 44.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice